Dar es Salaam. A comprehensive new study has raised concern over a “critical and troubling” rise in antimicrobial resistance ...

It turns out that even after extensive cleaning and sterilization, space missions still carry microbes. While this can sometimes endanger the missions, American researchers have ...

Taiwanese researchers have unlocked a key mechanism of a so-called “superbug” in a breakthrough that could lead to improved ...

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

ESCMID is the premier annual congress of the European Society of Clinical Microbiology and Infectious Diseases. It takes place from April 17 - 21, 2026 in Munich, Germany.

Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ‘superbug’ with a mortality rate that can be upwards of 50% when ...

A common wildflower used by our ancestors to treat wounds, sore throats, diarrhoea and gum disease could be the next weapon ...

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia ...

Acinetobacter baumannii is a critical-priority, multidrug-resistant pathogen that poses a severe threat in hospitals worldwide. A key structure of these bacteria is the protective layer of complex ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious ...